PinkDx, a Daly City, CA-based early-stage company focused on positively impacting the health of women throughout their life journey, raised $5M in additional Series A funding.
Backers included new investors Blue Venture Fund, Sandbox Clinical Ventures and BEVC.
The company intends to use the funds to further advance its first test, which is intended to clarify diagnosis for women presenting with a potential gynecologic cancer.
Led by Bonnie Anderson, cofounder, chairwoman and chief executive officer, PinkDx is an early-stage company focused on addressing the medical problems that women face by applying sophisticated scientific approaches to resolve them and providing answers that have a positive impact on their lives. Its first indication will focus on overcoming diagnostic challenges for women who present with general symptoms that could signal a gynecological cancer.
This brought the total raised in the upsized round to $45M.
The Series A financing was led by Catalio Capital Management, LP, The Production Board and Mountain Group Partners, with participation by Byers Capital, Mayo Clinic and new investors Blue Venture Fund, Sandbox Clinical Ventures and BEVC, founded by Risa Stack, Ph.D., and other industry-investment veterans.